QQQ   387.12 (-1.70%)
AAPL   164.77 (-0.32%)
MSFT   330.08 (-0.15%)
FB   310.60 (-4.27%)
GOOGL   2,821.03 (-0.60%)
AMZN   3,443.72 (-1.81%)
TSLA   1,095.00 (-4.35%)
NVDA   314.35 (-3.80%)
BABA   122.49 (-3.95%)
NIO   38.31 (-2.10%)
CGC   9.94 (-7.19%)
AMD   149.11 (-5.85%)
GE   93.00 (-2.09%)
MU   85.15 (+1.37%)
T   22.23 (-2.63%)
F   19.58 (+2.03%)
DIS   142.15 (-1.90%)
PFE   54.68 (+1.77%)
AMC   28.57 (-15.82%)
ACB   6.01 (-6.39%)
BA   188.19 (-4.88%)
QQQ   387.12 (-1.70%)
AAPL   164.77 (-0.32%)
MSFT   330.08 (-0.15%)
FB   310.60 (-4.27%)
GOOGL   2,821.03 (-0.60%)
AMZN   3,443.72 (-1.81%)
TSLA   1,095.00 (-4.35%)
NVDA   314.35 (-3.80%)
BABA   122.49 (-3.95%)
NIO   38.31 (-2.10%)
CGC   9.94 (-7.19%)
AMD   149.11 (-5.85%)
GE   93.00 (-2.09%)
MU   85.15 (+1.37%)
T   22.23 (-2.63%)
F   19.58 (+2.03%)
DIS   142.15 (-1.90%)
PFE   54.68 (+1.77%)
AMC   28.57 (-15.82%)
ACB   6.01 (-6.39%)
BA   188.19 (-4.88%)
QQQ   387.12 (-1.70%)
AAPL   164.77 (-0.32%)
MSFT   330.08 (-0.15%)
FB   310.60 (-4.27%)
GOOGL   2,821.03 (-0.60%)
AMZN   3,443.72 (-1.81%)
TSLA   1,095.00 (-4.35%)
NVDA   314.35 (-3.80%)
BABA   122.49 (-3.95%)
NIO   38.31 (-2.10%)
CGC   9.94 (-7.19%)
AMD   149.11 (-5.85%)
GE   93.00 (-2.09%)
MU   85.15 (+1.37%)
T   22.23 (-2.63%)
F   19.58 (+2.03%)
DIS   142.15 (-1.90%)
PFE   54.68 (+1.77%)
AMC   28.57 (-15.82%)
ACB   6.01 (-6.39%)
BA   188.19 (-4.88%)
QQQ   387.12 (-1.70%)
AAPL   164.77 (-0.32%)
MSFT   330.08 (-0.15%)
FB   310.60 (-4.27%)
GOOGL   2,821.03 (-0.60%)
AMZN   3,443.72 (-1.81%)
TSLA   1,095.00 (-4.35%)
NVDA   314.35 (-3.80%)
BABA   122.49 (-3.95%)
NIO   38.31 (-2.10%)
CGC   9.94 (-7.19%)
AMD   149.11 (-5.85%)
GE   93.00 (-2.09%)
MU   85.15 (+1.37%)
T   22.23 (-2.63%)
F   19.58 (+2.03%)
DIS   142.15 (-1.90%)
PFE   54.68 (+1.77%)
AMC   28.57 (-15.82%)
ACB   6.01 (-6.39%)
BA   188.19 (-4.88%)
NASDAQ:BLFS

BioLife Solutions Earnings Date, Estimates, & History

$37.50
-0.66 (-1.73%)
(As of 12/1/2021 12:00 AM ET)
Add
Compare
Today's Range
$36.94
$38.52
50-Day Range
$37.86
$58.55
52-Week Range
$28.15
$60.67
Volume
558,069 shs
Average Volume
350,017 shs
Market Capitalization
$1.53 billion
P/E Ratio
375.04
Dividend Yield
N/A
Beta
1.56

Earnings Summary

Upcoming
Earnings Date
Mar. 28
Estimated

Actual EPS
(Nov. 11)
-$0.19
Missed By -$0.21

Consensus EPS
(Nov. 11)
$0.02

Last Year's Q4 EPS
(11/5/2020)
-$0.02

Skip Charts & View Estimated and Actual Earnings Data

BioLife Solutions Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

BioLife Solutions Estimated Revenue and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

BioLife Solutions (NASDAQ:BLFS) Earnings Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany Guidance
Q1 20213($0.02)$0.02$0.00 
Q2 20213($0.02)$0.08$0.03 
Q3 20213$0.01$0.11$0.06 
Q4 20213$0.01$0.11$0.07 
FY 202112($0.02)$0.32$0.16
Q4 20221$0.00$0.00$0.00 

BLFS Earnings Information

BioLife Solutions last posted its earnings data on November 11th, 2021. The medical equipment provider reported ($0.19) earnings per share for the quarter, missing analysts' consensus estimates of $0.02 by $0.21. The business had revenue of $33.80 million for the quarter, compared to analyst estimates of $31.65 million. BioLife Solutions has generated $0.10 earnings per share over the last year ($0.10 diluted earnings per share) and currently has a price-to-earnings ratio of 375.0. Earnings for BioLife Solutions are expected to grow in the coming year, from ($0.26) to $0.16 per share. BioLife Solutions has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, March 28th, 2022 based off prior year's report dates.

BioLife Solutions (NASDAQ:BLFS) Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueActions
3/28/2022
(Estimated)
        
11/11/20219/30/2021$0.02($0.19)($0.21)($0.38)$31.65 million$33.80 million    
8/11/20216/30/2021$0.03($0.12)($0.15)($0.19)$28.32 million$31.20 million    
5/12/20213/31/2021($0.01)($0.03)($0.02)$0.05$15.60 million$16.85 million  
3/21/202112/31/2020($0.02)($0.06)($0.04)$0.04$13.43 million$14.73 million  
11/5/2020Q3 2020($0.02)($0.02)$10.71 million$11.28 million
8/6/2020Q2 2020($0.01)($0.01)$0.68$9.68 million$9.92 million
5/14/2020Q1 2020$0.06+$0.06$0.13$12.09 million$12.16 million
3/11/202012/31/2019($0.02)$0.02+$0.04($0.02)$8.72 million$8.30 million  
11/12/2019Q3 2019$0.01$0.01($0.35)$7.65 million$6.60 million
8/8/2019Q2 2019$0.02$0.0416+$0.0216$0.05$6.59 million$6.70 million
5/9/20193/31/2019$0.03$0.03$0.04$5.67 million$5.77 million
3/14/2019Q4$0.04$0.04$0.04$5.47 million$5.46 million
11/8/20189/30/2018$0.04$0.05+$0.01$0.05$5.19 million$5.29 million  
8/9/2018Q2 2018$0.04$0.05+$0.01$0.05$5.20 million$5.18 million
5/10/2018Q1 2018$0.0070($0.01)($0.0170)($0.01)$3.81 million$3.82 million
3/8/2018Q4 2017($0.0350)($0.05)($0.0150)($0.05)$3.10 million$3.13 million  
11/9/2017Q3 2017($0.06)($0.03)+$0.03($0.03)$2.60 million$2.96 million
8/10/2017Q2 2017($0.06)($0.06)($0.06)$2.40 million$2.56 million
5/11/2017Q1 2017($0.05)($0.07)($0.02)($0.07)$2.10 million$2.37 million
3/9/2017Q4 2016($0.07)($0.04)+$0.03$0.18$2.20 million$2.25 million  
11/10/2016Q316($0.08)($0.08)($0.08)$2.20 million$2.10 million
8/11/2016Q216($0.09)($0.11)($0.02)($0.11)$2.01 million$2.00 million  
5/12/2016Q1($0.08)($0.10)($0.02)($0.10)$2.20 million$1.85 million  
2/25/2016Q415($0.11)($0.09)+$0.02($0.09)$1.66 million$1.82 million  
11/12/2015Q315($0.10)($0.09)+$0.01($0.09)$1.67 million$1.60 million
8/6/2015Q215($0.10)($0.08)+$0.02($0.08)$1.60 million$1.50 million
5/7/2015Q1 2015($0.09)($0.09)($0.09)$1.47 million$1.50 million
3/12/2015Q4 2014($0.08)($0.08)($0.08)$1.76 million$1.67 million
11/6/2014Q3 2014($0.07)($0.07)($0.07)$1.24 million$1.24 million
8/7/2014Q2 2014($0.05)($0.07)($0.02)($0.07)$1.30 million$1.21 million  
5/8/2014Q1 2014$0.01($0.10)($0.11)($0.10)$2.33 million$2.07 million
2/12/2014Q4 2013($0.07)($0.10)($0.03)($0.10)$2.34 million$2.29 million
4/1/2013Q4 2012($0.14)($0.14)($0.14)
11/13/2012Q3 2012($0.14)($0.14)($0.14)
8/14/2012Q2 2012($0.14)($0.10)+$0.04($0.10)
5/14/2012Q1 2012($0.06)($0.06)($0.06)
3/26/2012Q4 2011($0.08)($0.08)($0.08)
11/14/2011Q3 2011($0.10)($0.10)($0.10)
8/12/2011Q2 2011($0.08)($0.08)($0.08)
5/16/2011Q1 2011($0.13)($0.13)($0.13)
11/10/2008Q3 2008($0.14)($0.14)($0.14)
(Earnings results data provided by Zacks Investment Research)












BioLife Solutions (NASDAQ:BLFS) Earnings Frequently Asked Questions

When is BioLife Solutions's earnings date?

BioLife Solutions has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, March 28th, 2022 based off last year's report dates. Learn more on BLFS's earnings history

Did BioLife Solutions beat their earnings estimates last quarter?

In the previous quarter, BioLife Solutions (NASDAQ:BLFS) missed the analysts' consensus estimate of $0.02 by $0.21 with a reported earnings per share (EPS) of ($0.19). Learn more on BLFS's earnings details

How can I listen to BioLife Solutions's earnings conference call?

The conference call for BioLife Solutions's latest earnings report can be listened to online. Listen to Conference Call

How can I read BioLife Solutions's conference call transcript?

The conference call transcript for BioLife Solutions's latest earnings report can be read online. Read Transcript

How much revenue does BioLife Solutions generate each year?

BioLife Solutions (NASDAQ:BLFS) has a recorded annual revenue of $48.09 million.

How much profit does BioLife Solutions generate each year?

BioLife Solutions (NASDAQ:BLFS) has a recorded net income of $2.67 million. BLFS has generated $0.10 earnings per share over the last four quarters.

What is BioLife Solutions's price-to-earnings ratio?

BioLife Solutions (NASDAQ:BLFS) has a trailing price-to-earnings ratio of 375.04.

What is BioLife Solutions's EPS forecast for next year?

BioLife Solutions's earnings are expected to grow from ($0.26) per share to $0.16 per share in the next year.

This page was last updated on 12/1/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.